These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 34990406)
1. Donor NKG2C homozygosity contributes to CMV clearance after haploidentical transplantation. Yu XX; Shang QN; Liu XF; He M; Pei XY; Mo XD; Lv M; Han TT; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Zhao XY; Huang XJ JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34990406 [TBL] [Abstract][Full Text] [Related]
2. Characterization of IFNγ-producing natural killer cells induced by cytomegalovirus reactivation after haploidentical hematopoietic stem cell transplantation. Jin F; Lin H; Gao S; Wang H; Yan H; Guo J; Hu Z; Jin C; Wang Y; Wang Z; Zhao Y; Liu Y; Zheng X; Tan Y; Li W; Dai Y; Yang Y Oncotarget; 2017 Jan; 8(1):51-63. PubMed ID: 27980216 [TBL] [Abstract][Full Text] [Related]
3. Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation. Cao K; Marin D; Sekine T; Rondon G; Zhao W; Smith NT; Daher M; Wang Q; Li L; Saliba RM; Pingali R; Popat U; Hosing C; Olson A; Oran B; Basar R; Mehta RS; Champlin R; Shpall EJ; Rezvani K Front Immunol; 2018; 9():2444. PubMed ID: 30405633 [TBL] [Abstract][Full Text] [Related]
4. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation. Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275 [TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440 [TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. Foley B; Cooley S; Verneris MR; Curtsinger J; Luo X; Waller EK; Anasetti C; Weisdorf D; Miller JS J Immunol; 2012 Nov; 189(10):5082-8. PubMed ID: 23077239 [TBL] [Abstract][Full Text] [Related]
7. Dissection of the NKG2C NK cell response against Puumala Orthohantavirus. Vietzen H; Hartenberger S; Aberle SW; Puchhammer-Stöckl E PLoS Negl Trop Dis; 2021 Dec; 15(12):e0010006. PubMed ID: 34871302 [TBL] [Abstract][Full Text] [Related]
8. Early and Sustained Expansion of Adaptive Natural Killer Cells Following Haploidentical Transplantation and CTLA4Ig-Primed Donor Lymphocyte Infusions Dissociate Graft-versus-Leukemia and Graft-versus-Host Effects. Jaiswal SR; Chakraborty S; Lakhchaura R; Shashi P; Mehta A; Soni M; Chakrabarti S Transplant Cell Ther; 2021 Feb; 27(2):144-151. PubMed ID: 33830023 [TBL] [Abstract][Full Text] [Related]
9. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia. Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229 [TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood. Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432 [TBL] [Abstract][Full Text] [Related]
11. Adaptive NKG2C+ NK Cell Response and the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients. Redondo-Pachón D; Crespo M; Yélamos J; Muntasell A; Pérez-Sáez MJ; Pérez-Fernández S; Vila J; Vilches C; Pascual J; López-Botet M J Immunol; 2017 Jan; 198(1):94-101. PubMed ID: 27913630 [TBL] [Abstract][Full Text] [Related]
12. NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients. Calabrese DR; Chong T; Wang A; Singer JP; Gottschall M; Hays SR; Golden JA; Kukreja J; Lanier LL; Tang Q; Greenland JR Transplantation; 2019 Mar; 103(3):493-501. PubMed ID: 30211828 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Evolution of the Adaptive NKG2C Ataya M; Redondo-Pachón D; Llinàs-Mallol L; Yélamos J; Alari-Pahissa E; Pérez-Sáez MJ; Altadill M; Raïch-Regué D; Vilches C; Pascual J; Crespo M; López-Botet M J Immunol; 2021 Oct; 207(7):1882-1890. PubMed ID: 34470855 [TBL] [Abstract][Full Text] [Related]
14. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets. Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Natural Killer Cells in HIV Patients Beginning Therapy with a High Burden of Cytomegalovirus. Ariyanto IA; Estiasari R; Edwar L; Makwana N; Lee S; Price P Immunol Invest; 2019 May; 48(4):345-354. PubMed ID: 30422022 [TBL] [Abstract][Full Text] [Related]
17. Adaptive Natural Killer Cell and Killer Cell Immunoglobulin-Like Receptor-Expressing T Cell Responses are Induced by Cytomegalovirus and Are Associated with Protection against Cytomegalovirus Reactivation after Allogeneic Donor Hematopoietic Cell Transplantation. Davis ZB; Cooley SA; Cichocki F; Felices M; Wangen R; Luo X; DeFor TE; Bryceson YT; Diamond DJ; Brunstein C; Blazar BR; Wagner JE; Weisdorf DJ; Horowitz A; Guethlein LA; Parham P; Verneris MR; Miller JS Biol Blood Marrow Transplant; 2015 Sep; 21(9):1653-62. PubMed ID: 26055301 [TBL] [Abstract][Full Text] [Related]
18. Emergence of human CMV-induced NKG2C+ NK cells is associated with CD8+ T-cell recovery after allogeneic HCT. van der Ploeg K; Sottile R; Kontopoulos T; Shaffer BC; Papanicolaou GA; Maloy MA; Cho C; Robinson KS; Perales MA; Le Luduec JB; Hsu KC Blood Adv; 2023 Oct; 7(19):5784-5798. PubMed ID: 37196646 [TBL] [Abstract][Full Text] [Related]
19. Alterations in NKG2A and NKG2C Subsets of Natural Killer Cells Following Epstein-Barr Virus Reactivation in CTLA4Ig-based Haploidentical Transplantation Is Associated With Increased Chronic Graft-Versus-Host Disease. Jaiswal SR; Bhakuni P; Bhagwati G; Aiyar HM; Chakrabarti A; Chakrabarti S Transplantation; 2020 Jan; 104(1):e23-e30. PubMed ID: 31478993 [TBL] [Abstract][Full Text] [Related]
20. Potential Beneficial Effects of Cytomegalovirus Infection after Transplantation. Litjens NHR; van der Wagen L; Kuball J; Kwekkeboom J Front Immunol; 2018; 9():389. PubMed ID: 29545802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]